Papers - NIIOKA Takenori
-
Influence of NAT2 polymorphisms on sulfamethoxazole pharmacokinetics in renal transplant recipients.
Kagaya Hideaki, Miura Masatomo, Niioka Takenori, Saito Mitsuru, Numakura Kazuyuki, Habuchi Tomonori, Satoh Shigeru
Antimicrob Agents Chemother 56 ( 2 ) 825 - 829 2012.2
-
Monitoring of mycophenolic acid predose concentrations in the maintenance phase more than one year after renal transplantation.
Miura Masatomo, Niioka Takenori, Kato Shoutaro, Kagaya Hideaki, Saito Mitsuru, Habuchi Tomonori, Satoh Shigeru
Ther Drug Monit 33 ( 3 ) 295 - 302 2011.6
-
Pharmacogenetic determinants for interindividual difference of tacrolimus pharmacokinetics 1 year after renal transplantation.
Miura M, Niioka T, Kagaya H, Saito M, Hayakari M, Habuchi T, Satoh S
J Clin Pharm Ther 36 ( 2 ) 208 - 216 2011.4
-
Clinical usefulness of limited sampling strategies for estimating AUC of proton pump inhibitors.
Niioka Takenori
Yakugaku Zasshi 131 ( 3 ) 407 - 413 2011.3
-
Influence of CYP2C19 and ABCB1 polymorphisms on plasma concentrations of lansoprazole enantiomers after enteral administration.
Miura Masatomo, Motoyama Satoru, Hinai Yudai, Niioka Takenori, Endo Masahiro, Hayakari Makoto, Ogawa Jun-ichi
Xenobiotica 40 ( 9 ) 630 - 636 2010.9
-
Correlation between R/S enantiomer ratio of lansoprazole and CYP2C19 activity after single oral and enteral administration.
Miura Masatomo, Motoyama Satoru, Hinai Yudai, Niioka Takenori, Hayakari Makoto, Ogawa Jun-ichi, Suzuki Toshio
Chirality 22 ( 7 ) 635 - 640 2010.7
-
Optimal Dose of Levofloxacin in Elderly Patients with Streptococcus Pneumoniae Infection Based on Monte Carlo Simulation
Okamura Yuji, Niioka Takenori, Kimura Masahiko, Yasujima Minoru, Hayakari Makoto
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 36 ( 8 ) 592 - 598 2010
-
CYP2C19 genotype-based (R)-warfarin disposition assessment: some views on data analysis.
Niioka Takenori, Uno Tsukasa
J Clin Pharm Ther 34 ( 5 ) 611 - 612 2009.10
-
Early phase limited sampling strategy characterizing tacrolimus and mycophenolic acid pharmacokinetics adapted to the maintenance phase of renal transplant patients.
Miura Masatomo, Satoh Shigeru, Niioka Takenori, Kagaya Hideaki, Saito Mitsuru, Hayakari Makoto, Habuchi Tomonori, Suzuki Toshio
Ther Drug Monit 31 ( 4 ) 467 - 474 2009.8
-
Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations.
Fujii Akira, Yasui-Furukori Norio, Nakagami Taku, Niioka Takenori, Saito Manabu, Sato Yasushi, Kaneko Sunao
Drug Des Devel Ther 2 139 - 144 2009.2
-
Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomers.
Niioka Takenori, Miura Masatomo, Uno Tsukasa, Yasui-Furukori Norio, Hayakari Makoto, Tateishi Tomonori, Suzuki Toshio
Eur J Clin Pharmacol 64 ( 5 ) 503 - 509 2008.5
-
Limited sampling strategy for simultaneous estimation of the area under the concentration-time curve of tacrolimus and mycophenolic acid in adult renal transplant recipients.
Miura Masatomo, Satoh Shigeru, Niioka Takenori, Kagaya Hideaki, Saito Mitsuru, Hayakari Makoto, Habuchi Tomonori, Suzuki Toshio
Ther Drug Monit 30 ( 1 ) 52 - 59 2008.2
-
Estimation of CYP2C19 activity by the omeprazole hydroxylation index at a single point in time after intravenous and oral administration.
Niioka Takenori, Uno Tsukasa, Sugimoto Katsuyoshi, Sugawara Kazunobu, Hayakari Makoto, Tateishi Tomonori
Eur J Clin Pharmacol 63 ( 11 ) 1031 - 1038 2007.11
-
Simultaneous determination of warfarin enantiomers and its metabolite in human plasma by column-switching high-performance liquid chromatography with chiral separation.
Uno Tsukasa, Niioka Takenori, Hayakari Makoto, Sugawara Kazunobu, Tateishi Tomonori
Ther Drug Monit 29 ( 3 ) 333 - 339 2007.6
-
Different serum concentrations of steady-state valproic acid in two sustained-release formulations.
Yasui-Furukori Norio, Saito Manabu, Nakagami Taku, Niioka Takenori, Sato Yasushi, Fujii Akira, Kaneko Sunao
Psychiatry Clin Neurosci 61 ( 3 ) 308 - 312 2007.6
-
Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
Niioka Takenori, Uno Tsukasa, Yasui-Furukori Norio, Takahata Takenori, Shimizu Mikiko, Sugawara Kazunobu, Tateishi Tomonori
Cancer Chemother Pharmacol 59 ( 5 ) 575 - 580 2007.4
-
Effect of itraconazole on pharmacokinetics of paroxetine: the role of gut transporters.
Yasui-Furukori Norio, Saito Manabu, Niioka Takenori, Inoue Yoshimasa, Sato Yasushi, Kaneko Sunao
Ther Drug Monit 29 ( 1 ) 45 - 48 2007.2
-
Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations.
Uno Tsukasa, Niioka Takenori, Hayakari Makoto, Yasui-Furukori Norio, Sugawara Kazunobu, Tateishi Tomonori
Eur J Clin Pharmacol 63 ( 2 ) 143 - 149 2007.2
-
Terbinafine increases the plasma concentration of paroxetine after a single oral administration of paroxetine in healthy subjects.
Yasui-Furukori Norio, Saito Manabu, Inoue Yoshimasa, Niioka Takenori, Sato Yasushi, Tsuchimine Shoko, Kaneko Sunao
Eur J Clin Pharmacol 63 ( 1 ) 51 - 56 2007.1
-
Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve.
Niioka Takenori, Uno Tsukasa, Yasui-Furukori Norio, Shimizu Mikiko, Sugawara Kazunobu, Tateishi Tomonori
Eur J Clin Pharmacol 62 ( 10 ) 855 - 861 2006.10